Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real-world evidence from primary care

Jul-21

AUTHORS : Professor Sanjoy K. Paul, PhD, The Royal Melbourne Hospital, University of Melbourne, City Campus, 7 East, Main Building Grattan Street, Parkville, Victoria 3050, Australia – Email: sambhupaul@hotmail.com / sanjoy.paul@unimelb.edu.au – Profile: https://medicine.unimelb.edu.au/school-structure/medicine-and-radiology/research/research-platforms/melbourne-epicentre

JOURNAL : Diabetes, Obesity & Metabolism

REFERENCE: 23(7):1518-1531

DOI : 10.1111/dom.14364

Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real-world evidence from primary care

More publications

Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis

Using repeated measurements to predict cardiovascular risk in patients with type 2 diabetes Mellitus

Inequalities in the management of diabetic kidney disease in UK primary care: A cross-sectional analysis of a large primary care database